Onderneming Icosavax, Inc.
Aandelen
ICVX
US45114M1099
Biotechnologie & Medisch Onderzoek
Vakgebied
Aantal werknemers: 60
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Thomas Russo
DFI | Director of Finance/CFO | 52 | 01-06-21 |
Jennifer Raymond
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Tech/Sci/R&D Officer | 64 | 01-09-18 | |
Douglas Holtzman
CTO | Chief Tech/Sci/R&D Officer | 60 | 01-08-19 |
Lori Stewart
HRO | Human Resources Officer | - | - |
Cassia Cearley
PRN | Corporate Officer/Principal | 42 | 01-12-19 |
Ami Shah Brown
LAW | General Counsel | - | - |
General Counsel | 54 | 10-09-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 50 090 341 | 48 755 518 ( 97,34 %) | 0 | 97,34 % |
Bedrijfsgegevens
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
-1,78% | 41,36 mld. | |
+47,70% | 41,3 mld. | |
+4,01% | 39,61 mld. | |
-15,14% | 25,62 mld. | |
+3,16% | 24,09 mld. | |
-24,08% | 18,38 mld. | |
-2,67% | 11,82 mld. | |
+24,76% | 11,85 mld. | |
+7,01% | 11,07 mld. |